@garyansel
Joined August 2013
  • Tweets133
  • Following81
  • Followers520
25Media
Replying to @CDCDirector
@CDCDirector @CDCemergency @DrWheatley @krosenfieldMD @jgranadacrf @MidOhioVascular @aorticsurgeon @Sunnybrook @JoshuaBeckmanMD when you can’t get N95 and want better protect use fullface snorkel and paper mask taped snuggly around edges
4
16
3
34
.@garyansel presents the 5-year outcomes w #DCB alone vs. DCB plus #stenting from the IN.PACT Global study (@Medtronic), saying that in a complex lesion subset of patients, the Admiral DCB “demonstrates durable safety and effectiveness” #CX2021
2
2
gary ansel retweeted
Adam Ansel@AdamAnsel11 Mar 2021
Cook Medical receives FDA Breakthrough Device Designation for Zenith® Fenestrated+ Endovascular Graft | Newsroom cookmedical.com/newsroom/bre…
3
4
Have you seen our 5-year data on Zenith Alpha Thoracic? #DurableByDesign #ZenithAlphaThoracic
Cook Vascular@cookvascular5 Feb 2021
Check out our 5-year data on Zenith Alpha Thoracic endovascular graft. bit.ly/2MKfHgG #ZenithAlphaThoracic #CookVascular #endovascular #graft
1
2
1
Now we can start to really look at transradial PAD treatments with a straight face
Cat Jennings@bsc_vascular23 Nov 2020
First Transradial #RangerDCB case HT @sahilparikhmd the low profile and 150cm shaft length opens up new approaches to treat patients #Radial #Pedal #PAD #RangerDCB #EvidenceBasedMedicine
4
Not much different from the tactics hospitals and insurers use to get prices they want. Put the customer or the patient in the middle. How about a discount while we are not getting the product we paid for?
AT&T
@ATT6 Dec 2020
Replying to @garyansel
Gary, we have every intention of getting TEGNA’s stations back as soon as possible, but by law, TEGNA has exclusive control over them. We will do all we can to resolve this soon. For more information on viewing options and credits please visit sm.att.com/eb27e483
#DirectTV #CBS isn’t it crazy that these two feud and the customer gets less of a product for the same billing charge? Cmon man
1
1
1
Rob is one of the most respected “patient first” advocates in America. Must be some very non patient first decisions occurring at Beaumont. Problem is that institution was a model for years and certainly worry about the wrong model for others to follow now
Chris White@Stent4U27 Nov 2020
I don't know any of the details, but when "Hall of Fame" interventional cardiologist Rob Safian speaks, I listen.
1
Hey @ATT why do you need a credit check for me to get ATT TV? I have FOUR services with you now & pay $480 / month and HAVE NEVER MISSED A PAYMENT. Your phone person said it was like a car purchase? Seriously? When I asked to speak with the manager, he hung up on me. WTF! @FCC
1
1
5
Replying to @KHaysDNP @OhioHealth @MichaelJolly77 @MidOhioVascular @hufcm @garyansel @jkates79
Great work @KHaysDNP. We now have some data on the role of DOACs after venous stent placement. Thank you. @JVascSurg
1
3
gary ansel retweeted
Mr. Ohio
@MrOH1O26 Aug 2020
Ohio State would have been the best team in the country this year.
67
132
29
1,561
Congratulations a great team
Chris White@Stent4U26 Aug 2020
Kudos to a great team led by Dr. Steve Ramee and Steve Jenkins bringing cutting edge technology to the John Ochsner Heart & Vascular Institute. @OchsnerHealth
1
We looked at a series of 5 of these we had stent grafted and looked awesome after the procedure. They all occluded on anticoagulation. Rec surg repair and if not possible his risk of rupture probably is lower than the risk of his co-morbidities if he is a non surgical candidate
Mehdi Shishehbor, DO@shishem20 Aug 2020
FLU: Cine run of large RCA aneurysm. not a surgical candidate, approach? ⁦@SVRaoMD⁩ ⁦@ajaykirtane⁩ ⁦@DrMauricioCohen⁩ ⁦@PSorajja⁩ ⁦@FarshadForouz⁩ ⁦@thammad2010⁩ ⁦@MarcPPelletier⁩ ⁦@UHhospitals⁩ ⁦@cvinnovations⁩ ⁦@SCAI⁩
6
Tele health has a role but we are under valuing the true high value of a physical exam and the benefit the doctor patient relationship.
Stanford Medicine
@StanfordMed11 Aug 2020
"I think telehealth is here to stay. ... But I think we’re discovering that, even as we go back to in-person visits, there’s a lot we’re going to retain in the virtual world." -Dean Lloyd Minor on #COVID19 and the future of medicine. stan.md/30NdYf6
2
3
13
This must be demoralizing to the bright hard working employees of the CDC. Just does not pass the common sense test
Chris White@Stent4U15 Jul 2020
Wait a minute. He doesn't want the CDC guidance to influence how/when schools are opened? Does he think he is speaking to a Covidiot?
1
Awesome new data as we continue noncovid related patient care advancements. Congratulations to all the presenters and the medical device industry that provides us with improved vascular patient care options
The VIVA Foundation
@VIVAPhysicians25 Jun 2020
HAPPENING NOW: Click the link below to join the Late-Breaking Clinical Trials Livestream Hear the latest data from 5 unreleased clinical trials. Each presentation will be followed by Q&A from our panel of clinicians and regulatory experts: vivaphysicians.org/livestrea…
1
6
sorry for the typo. It’s respect and not a weakness to utilized a mask in public places
gary ansel@garyansel13 Jun 2020
It’s respect no a weakness to utilize a mask for public places
7
It’s respect no a weakness to utilize a mask for public places
Chris White@Stent4U12 Jun 2020
Going the wrong way with Phase 2 reopening next week. Wear your masks and keep your distance.
2
1
1
8
Honored to have been able to provide an overview of the importance of the VIVA independent patient level data of paclitaxel fempop devices at CX 2020 with epublished abstract and pending publication in the Journal of Circulation
CX Symposium@CXSymposium26 May 2020
“The VIVA IPD data has and will continue to have high impact due to the richness of the dataset,” @garyansel tells CX 2020 LIVE audience #CX2020 Join the live discussion: cx2020live.com/
2
3
2
21
When as treated in the first 6 months is taken into account no mortality difference. The drop with more data acquired also is strong evidence of assertainment bias. We have typically learned and paralleled the coronary data so PTX moving to Limus has always been on the horizon
Sean Lyden@drseanlyden11 May 2020
This has different trials than Katsanos. (Limited to FDA approved products) with a drop in mortality risk relative 27% absolute 4.6%. Likely more data at long term will clarify
1
4
Load more